Blueshift Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Blueshift Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,641	Closed	-$282K	–	510
2024 Q3	$282K	Buy	+6,641	New	+$282K	0.07%	286
2022 Q3	–	Sell	-4,253	Closed	-$252K	–	842
2022 Q2	$252K	Buy	+4,253	New	+$349K	0.04%	501
2021 Q1	–	Sell	-3,950	Closed	-$378K	–	1073
2020 Q4	$378K	Buy	3,950 +1,139	+41%	+$117K	0.04%	471
2020 Q3	$319K	Buy	+2,811	New	+$295K	0.04%	433
2020 Q1	–	Sell	-7,869	Closed	-$469K	–	662
2019 Q4	$469K	Buy	+7,869	New	+$485K	0.05%	469

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Blueshift Asset Management's TNDM Position: Q4 2024 in Review

Blueshift Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 6,641 shares — an estimated $282K sold.

Blueshift Asset Management first reported a position in TNDM in Q4 2019 and held it in 5 quarters. The position peaked at $469K in Q4 2019. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

Blueshift Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
Blueshift Asset Management sold 6,641 Tandem Diabetes Care shares in Q4 2024, an estimated $282K.
Blueshift Asset Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 5 quarters.
Blueshift Asset Management's Tandem Diabetes Care position peaked at $469K in Q4 2019.
316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Blueshift Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.